Identify non-immune extrinsic causes of hemolysis โ microangiopathic, mechanical โ for ASCP hematology MCQs.
Chapter 14 โ EXTRINSIC DEFECTS LEADING TO INCREASED ERYTHROCYTE DESTRUCTION: NONIMMUNE CAUSES
1 ยท Priority Table & Quick Foundation
| Topic | Priority | Why It’s Tested |
|---|---|---|
| Microangiopathic hemolytic anemia (MAHA): schistocytes + thrombocytopenia | HIGH | Rodak review Q1โQ2; the core pattern of the chapter |
| TTP: ADAMTS-13 deficiency, ULVWF, normal PT/PTT, plasma exchange | HIGH | Mechanism and treatment; Rodak Q3 and Q11 case |
| TTP vs HUS vs HELLP vs DIC (platelets, renal, liver enzymes, coagulation tests) | HIGH | Differentiation โ PT/PTT separates DIC (Rodak Q4) |
| Malaria: 5 species morphology, erythrocytic cycle length, age of RBC invaded | HIGH | Film identification; Rodak Q6โQ8 and case study |
| Thick vs thin films: preparation, staining, purpose, number of fields | HIGH | Specimen and procedure questions |
| Babesiosis vs P. falciparum (tetrads, no pigment, no gametocytes) | HIGH | Classic look-alike on the film; Rodak Q9 |
| Traumatic cardiac hemolysis vs exercise-induced hemoglobinuria | MEDIUM | Macroangiopathic causes โ normal platelets (Rodak Q5) |
| Mechanisms of anemia in P. falciparum; PfEMP1, cytoadherence, cerebral malaria | MEDIUM | Pathophysiology (Rodak Q7) |
| Clostridial sepsis: ฮฑ-toxin, spherocytes, massive intravascular hemolysis | MEDIUM | Film + history matching |
| Extensive burns: schistocytes, spherocytes, microspherocytes within 24 h | MEDIUM | Rodak Q10 |
| Protective polymorphisms (Duffy-negative, Hb S, Hb C, Hb E, thalassemia, G6PD) | MEDIUM | Geneticsโinfection link |
| Bartonellosis (Oroya fever), venoms, drugs/chemicals (dapsone, naphthalene) | LOW | Less common; recognition only |
| Rapid antigen test (BinaxNOW: HRP-II, aldolase), PCR, fluorescent dyes | LOW | Other diagnostic methods |
Focus: the MAHA pattern (schistocytes, โ platelets), what separates TTP, HUS, HELLP and DIC, the ADAMTS-13 mechanism, the malaria species table (RBC size, stippling, forms seen, cycle length), thick vs thin film technique, and Babesia vs falciparum. Skim: epidemiology numbers, Babesia species by U.S. state, bartonellosis history, venom species names.
Quick Foundation โ from zero
- In extrinsic hemolytic anemias the RBC is normal โ something outside the cell damages it. Transfuse normal cells into these patients and they get destroyed too.
- This chapter covers the nonimmune causes (no antibody). Immune hemolysis is the next chapter.
- The common thread is physical or mechanical injury: cells get sliced by clots in tiny vessels (microangiopathic), battered by heart valves or foot strikes (macroangiopathic), invaded by parasites (malaria, Babesia), attacked by bacterial toxins (Clostridium), or damaged by drugs, venoms and heat.
- The peripheral blood film is the key clue: schistocytes (fragments), spherocytes or intracellular organisms.
- In MAHA, platelets are used up forming the microthrombi, so thrombocytopenia accompanies the schistocytes. In macroangiopathic hemolysis, platelets stay normal.
Think of RBCs as cyclists on a road. In MAHA, wires (fibrin/platelet strands) are strung across narrow side streets โ cyclists get sliced in half (schistocytes), and the wire material (platelets) is used up. In macroangiopathic hemolysis, the road itself is dangerous โ a broken bridge (faulty heart valve) or pounding potholes (foot strikes in runners). In malaria, a hijacker climbs aboard and eats the cyclist from inside. Clostridium is acid thrown on the road โ it dissolves the tires (membrane lipids).
Several of these are emergencies where the laboratory makes the call. Seeing schistocytes with severe thrombocytopenia and normal PT/PTT should trigger urgent reporting โ untreated TTP is often fatal, and plasma exchange saves 80โ90%. Finding P. falciparum or P. knowlesi means treatment must start without delay. Platelet transfusion is avoided in TTP*.
*Platelet transfusion caution in TTP is standard clinical teaching, not stated in Rodak Ch. 25.
| Concept | Plain-English Explanation |
|---|---|
| Extrinsic hemolytic anemia | Normal RBCs destroyed by a cause outside the cell |
| Schistocyte | RBC fragment formed when the cell is sheared (helmet cell is one type) |
| Microangiopathic (MAHA) | Shearing in small vessels partly blocked by microthrombi or damaged endothelium |
| Thrombotic microangiopathy | Another name for MAHA โ stresses the platelet-rich microthrombi |
| Macroangiopathic | Injury from the heart or large vessels (valves) or external impact |
| ADAMTS-13 | Enzyme that trims ultra-large VWF multimers into smaller, less sticky pieces |
| Parasitemia | Percentage of RBCs containing parasites |
| Hypnozoite | Dormant liver stage of P. vivax and P. ovale that causes relapse |
2 ยท Core Content Tables
2.1 Extrinsic Nonimmune Causes of Hemolytic Anemia (Rodak Box 25-1)
| Group | Conditions | Key Film Clue |
|---|---|---|
| Microangiopathic hemolytic anemia | TTP ยท HUS ยท HELLP syndrome ยท DIC | Schistocytes, helmet cells + โ platelets |
| Macroangiopathic hemolytic anemia | Traumatic cardiac hemolytic anemia ยท exercise-induced hemoglobinuria | Schistocytes (cardiac), normal platelets |
| Infection | Malaria ยท babesiosis ยท clostridial sepsis ยท bartonellosis | Intracellular organisms; spherocytes in clostridial sepsis |
| RBC injury โ other | Chemicals ยท drugs ยท venoms ยท extensive burns | Heinz bodies (oxidants); schistocytes/microspherocytes (burns) |
2.2 Microangiopathic Hemolytic Anemia โ General Features
| Feature | Details |
|---|---|
| Mechanism | RBCs pass rapidly through turbulent areas of small vessels partly blocked by microthrombi or damaged endothelium โ membranes sheared intravascularly |
| Fragments | Membranes reseal with little Hb loss, but fragments (schistocytes) are distorted and rigid โ cleared by the spleen (extravascular) |
| Severe cases | Fragmentation so severe that intravascular hemolysis also occurs: hemoglobinemia, hemoglobinuria, markedly โ haptoglobin |
| Hemolysis labs | โ Hb, โ retics, โ indirect bilirubin, โ LDH, โ haptoglobin, โ urine urobilinogen |
| Film | Schistocytes (characteristic), helmet cells, occasional microspherocytes; polychromasia and nRBCs depending on severity |
| Thrombocytopenia | Platelets consumed in the microthrombi โ also called thrombotic microangiopathies |
| Main examples | TTP, HUS, HELLP syndrome, DIC |
2.3 Typical Laboratory Findings in TTP and HUS (Rodak Box 25-2)
| Category | Findings |
|---|---|
| Hematologic | โ Hemoglobin ยท โ platelets ยท โ reticulocyte count |
| Peripheral blood film | Schistocytes ยท polychromasia ยท nucleated RBCs (severe cases) |
| Biochemical | Markedly โ LDH (ischemia + hemolysis; more in TTP) ยท โ total and indirect bilirubin ยท โ haptoglobin ยท hemoglobinemia ยท hemoglobinuria ยท proteinuria, hematuria, casts (renal failure; more in HUS) |
2.4 Thrombotic Thrombocytopenic Purpura (TTP)
| Feature | Details |
|---|---|
| Definition | Rare, life-threatening: abrupt MAHA, severe thrombocytopenia, markedly โ LDH; neurologic dysfunction, fever and renal failure may occur but are not consistent |
| Who | Most common in adults in their fourth decade; more females than males; can occur at any age |
| Cause | Deficiency of ADAMTS-13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) โ the VWF-cleaving protease |
| Normal ADAMTS-13 role | Cleaves ultra-large VWF multimers (ULVWF) at the A2 domain into smaller, less active pieces. Cleavage sites and the GP Ibฮฑ binding site (A1 domain) are hidden until ULVWF is unrolled: (1) release from endothelial cells, (2) high shear in small vessels, (3) binding to subendothelial collagen after injury |
| When deficient | ULVWF stays on endothelial cells, unrolls under shear โ platelets bind A1 โ plateletโVWF microthrombi block small vessels โ severe thrombocytopenia, ischemia (brain, kidney), MAHA โ striking โ LDH |
| Idiopathic TTP | No precipitating event; autoantibodies (usually IgG; can be IgM or IgA) inhibit ADAMTS-13 โ severe deficiency |
| Secondary TTP | Infections, pregnancy, surgery, trauma, inflammation, disseminated malignancy (may โ synthesis); HSCT, autoimmune disorders, HIV, drugs (quinine, ticlopidine, trimethoprim) โ inhibitory reaction. Deficiency less severe |
| Inherited TTP | Upshaw-Schรผlman syndrome: ADAMTS13 gene mutations (>75 known); homozygous or compound heterozygous; infancy/childhood with recurrences, or adulthood when stressed (pregnancy, severe infection) |
2.5 TTP โ Laboratory Findings
| Feature | Details |
|---|---|
| CBC | Hb 8โ10 g/dL ยท platelets 10โ30 ร 10โน/L ยท WBC often โ, immature granulocytes may appear |
| Film | Schistocytes; polychromasia and nRBCs once marrow responds |
| Marrow | Erythroid hyperplasia; normal number of megakaryocytes |
| Chemistry | LDH markedly โ; haptoglobin โ; indirect bilirubin rise delayed several days after acute onset |
| Urine | Hemoglobinuria (extensive intravascular hemolysis); variable protein, RBCs, casts |
| Coagulation | PT and PTT usually within reference interval โ separates TTP from DIC |
| ADAMTS-13 | Idiopathic and inherited: activity <5โ10% of normal. Secondary: deficiency less severe. Autoantibodies detected in idiopathic, absent in inherited |
2.6 TTP โ Treatment
| Feature | Details |
|---|---|
| Idiopathic | Plasma exchange โ 80โ90% respond (removes autoantibody, supplies ADAMTS-13 from donor plasma). Must be started quickly to avoid a fatal outcome. Corticosteroids suppress autoimmunity |
| Relapse | About one third of responders relapse; rituximab (anti-CD20) helps some |
| Secondary | Generally poor response to plasma exchange; poor prognosis except TTP related to autoimmune disease, pregnancy or ticlopidine |
| Inherited | Plasma exchange not required โ infuse fresh frozen plasma to supply ADAMTS-13 |
2.7 Hemolytic Uremic Syndrome (HUS)
| Feature | Details |
|---|---|
| Definition | MAHA + thrombocytopenia + acute renal failure from damage to glomerular endothelial cells |
| Typical (stx-HUS) | ~90% of HUS. Shiga toxinโproducing E. coli (STEC), e.g., O157:H7; also toxin-producing Shigella. Mostly young children. Acute gastroenteritis, often bloody diarrhea โ 5โ13 days later oliguria and renal damage; ~ยผ have neurologic signs |
| Shiga toxin mechanism | Stx-1 and Stx-2 (verotoxins) absorbed from the gut โ bind Gb3 (CD77) receptors on endothelial cells (glomerulus, brain) โ inhibit protein synthesis โ endothelial injury and apoptosis; cytokines make endothelium prothrombotic (tissue factor, adhesion molecules, โ ULVWF) โ plateletโfibrin thrombi โ acute renal failure |
| Stx-HUS treatment | No specific therapy; supportive (hydration, dialysis, transfusion). Resolves in 1โ3 weeks; favorable prognosis |
| Atypical (aHUS) | ~10%. Uncontrolled activation of the alternative complement pathway. 50โ70% inherited mutations: inactivating in factor H, factor I, membrane cofactor protein, thrombomodulin; activating in factor B and C3. Acquired form: autoantibodies to factor H (5โ10%). Triggers: HSCT, pregnancy, infection, inflammation, surgery, trauma |
| aHUS treatment | Plasma exchange/infusion of limited value; eculizumab (anti-C5) improves platelets and renal function โ may become therapy of choice |
| Labs vs TTP | Platelets only mildly to moderately โ; renal failure evident: โ creatinine, proteinuria, hematuria, hyaline, granular and RBC casts |
| Diagnostic challenge | aHUS vs TTP difficult; ADAMTS-13 assays lack sensitivity/specificity and aren’t widely available; complement gene testing too slow for initial decisions |
2.8 HELLP Syndrome
| Feature | Details |
|---|---|
| Name | Hemolysis, Elevated Liver enzymes, Low Platelet count |
| Frequency | <1% of all pregnancies; 10โ20% of pregnancies with severe preeclampsia; usually third trimester |
| Pathogenesis | Abnormal placental vasculature โ poor perfusion, hypoxia โ antiangiogenic proteins block placental growth factors (VEGF) โ maternal endothelial dysfunction โ platelet activation, fibrin deposition, especially in the liver |
| Labs | Anemia, hemolysis, schistocytes ยท platelets <100 ร 10โน/L (<50 = worse prognosis) ยท โ LDH (liver necrosis + hemolysis) ยท markedly โ AST |
| Key differentiator | PT and PTT within reference interval โ distinguishes HELLP from DIC |
| Treatment / outcome | Deliver the fetus and placenta ASAP; control seizures, hypertension, fluids. Mortality 3โ5% (mother), 9โ24% (fetus) |
2.9 Disseminated Intravascular Coagulation (DIC)
| Feature | Details |
|---|---|
| Definition | Widespread activation of hemostasis โ fibrin thrombi throughout the microvasculature โ organ damage + bleeding (consumed platelets and factors; secondary fibrinolysis) |
| Causes | Metastatic cancer, acute leukemias, infections, obstetric complications, crush/brain injury, acute hemolytic transfusion reactions, extensive burns, snake/spider envenomation, chronic inflammation |
| Film | Thrombocytopenia is consistent; schistocytes in only about half of patients |
| Key labs | Prolonged PT and PTT, โ fibrinogen, โ D-dimer โ distinguishes DIC from other MAHAs (covered in the hemostasis chapters) |
2.10 Comparing the Microangiopathies
| Feature | TTP | HUS (typical) | HELLP | DIC |
|---|---|---|---|---|
| Typical patient | Adult, 4th decade, female | Young child after bloody diarrhea | Pregnant, 3rd trimester, preeclampsia | Underlying disease (sepsis, cancer, obstetric) |
| Platelets | Severely โ (10โ30) | Mildโmoderate โ | <100 ร 10โน/L | โ (variable) |
| Schistocytes | Present | Present | Present | ~Half of cases |
| LDH | Markedly โ | โ | โ | โ* |
| Renal findings | Variable | Acute renal failure, โ creatinine, casts | โ | Possible |
| Liver enzymes (AST) | โ | โ | Markedly โ | Possible* |
| PT / PTT | Normal | Normal | Normal | Prolonged |
| Fibrinogen / D-dimer | Normal* | Normal* | Normal* | โ / โ |
| Key mechanism | ADAMTS-13 deficiency โ plateletโVWF thrombi | Shiga toxin (typical) or complement (atypical) | Placental endothelial dysfunction | Systemic coagulation activation |
| Treatment | Plasma exchange, steroids, rituximab | Supportive; eculizumab (aHUS) | Delivery | Treat the cause |
*Cells marked with an asterisk are general hematology expectations not stated explicitly in Rodak Ch. 25.
2.11 Traumatic Cardiac Hemolytic Anemia (Macroangiopathic)
| Feature | Details |
|---|---|
| Cause | Prosthetic heart valves โ turbulent flow through and around the device; severe hemolysis usually from paravalvular leaks. Also native valve disease before surgery |
| Severity | Usually mild; marrow compensates, anemia uncommon. Severe: pallor, fatigue, even heart failure |
| Film | Schistocytes characteristic |
| Labs | โ Retics ยท platelets within reference interval ยท โ LDH ยท โ indirect bilirubin ยท โ plasma Hb ยท โ haptoglobin ยท hemoglobinuria (severe) |
| Chronic hemoglobinuria | Hemosiderinuria and โ serum ferritin (urinary iron loss) โ may become microcytic (iron deficiency); otherwise normocytic |
| Treatment | Surgical repair/replacement if transfusion-dependent; iron supplements for hemoglobinuria; folic acid for increased erythropoiesis |
2.12 Exercise-Induced Hemoglobinuria (March Hemoglobinuria*)
| Feature | Details |
|---|---|
| Who | Long-distance runners; to a lesser extent intensive cycling and swimming; strenuous hand drumming. Frank hemoglobinuria is rare |
| Proposed causes | Mechanical trauma from repeated forceful impact of feet/hands on hard surfaces; increased RBC susceptibility to oxidative stress; exercise-induced changes in membrane skeletal proteins |
| Labs | โ Haptoglobin ยท โ free plasma Hb ยท hemoglobinuria after strenuous exercise ยท slight โ MCV and retics |
| Film | Schistocytes not present except in rare cases |
| Anemia | Usually none unless hemoglobinuria is severe and recurrent |
| Diagnosis | Diagnosis of exclusion โ other causes of hemolysis and hemoglobinuria must be ruled out |
| Management | No treatment; padding on the feet, softer running surfaces, or stopping the activity if severe |
*’March hemoglobinuria’ is the classic alternate name from general references.
2.13 Malaria โ Epidemiology & Species
| Feature | Details |
|---|---|
| Organism | Protozoa of genus Plasmodium: P. falciparum and P. vivax (most human infections), P. ovale, P. malariae, and P. knowlesi (macaque parasite) |
| P. knowlesi | Easily misdiagnosed as P. malariae by microscopy; PCR showed many Malaysian ‘P. malariae’ cases were P. knowlesi; widespread in Malaysia and Southeast Asia |
| Burden (2012) | ~3.4 billion people at risk; 207 million cases; 627,000 deaths, mostly children <5 years. Deaths: Africa 90%, Southeast Asia 7%, Eastern Mediterranean 3% |
| United States | 1925 cases in 2011, nearly all travel-related; P. falciparum and P. vivax most common |
| Other transmission | Congenital, blood transfusion, organ transplantation, shared needles |
2.14 Plasmodium Life Cycle
| Feature | Details |
|---|---|
| Vector | Bite of an infected female Anopheles mosquito injects sporozoites from its salivary gland |
| Exoerythrocytic schizogony | Sporozoites invade hepatocytes; after 5โ16 days liver cells rupture, releasing tens of thousands of merozoites |
| Erythrocytic schizogony | Merozoite โ ring form โ mature trophozoite โ immature schizont (chromatin dividing) โ mature schizont (merozoites) โ RBC ruptures โ new RBCs infected |
| Fever pattern | Cycles become synchronous โ paroxysms of fever and chills at a frequency that depends on the species |
| Hypnozoites | Dormant liver stages of P. vivax and P. ovale โ relapse months or years later |
| Sexual stage | Some merozoites form male and female gametocytes โ ingested by mosquito โ zygote โ ookinete โ oocyst โ sporozoites migrate to salivary glands |
2.15 Malaria โ Pathogenesis
| Feature | Details |
|---|---|
| Outcomes of a bite | No infection ยท asymptomatic parasitemia ยท uncomplicated malaria (symptoms, no organ dysfunction) ยท severe malaria (major organ dysfunction) |
| Risk groups (endemic areas) | Children <5 years and women in first pregnancy; travelers and low-transmission areas โ all ages |
| Severe malaria | Mostly P. falciparum (P. vivax and P. knowlesi can too); hyperparasitemia >2โ5%; ARDS, metabolic acidosis, shock, renal/hepatic failure, hypoglycemia, severe anemia (Hb <5 g/dL), poor pregnancy outcome, cerebral malaria; fatality 10โ20% even with treatment |
| Causes of anemia | (1) Lysis of infected RBCs during schizogony ยท (2) immune destruction of infected AND noninfected RBCs in the spleen (parasite proteins bind noninfected cells โ Ig/complement โ splenic removal; oxidative damage) ยท (3) inhibition of erythropoiesis and ineffective erythropoiesis (TNF-ฮฑ, IFN-ฮณ; IL-6 โ โ hepcidin โ โ iron) |
| Hemozoin | Toxic ‘malaria pigment’ from Hb metabolism; released at schizogony โ inflammation and cytokine imbalance |
| P. falciparum cytoadherence | Infected RBCs express PfEMP1 โ bind CD36 (platelets, some endothelium) and other receptors โ adhere in brain, heart, lung, liver, kidney, dermis, placenta โ obstruction, โ Oโ, escape splenic clearance |
| Cerebral malaria | Complex of VWF (from stimulated endothelium), platelets and infected RBCs bound to platelet CD36; a PfEMP1 variant binds endothelial protein C receptor (EPCR) โ blocks protein C activation โ local hypercoagulability |
| Placental malaria | Local inflammation โ severe maternal anemia, low birth weight, premature delivery, fetal loss |
2.16 RBC Age Preference & Protective Traits
| Feature | Details |
|---|---|
| Reticulocytes only | P. vivax and P. ovale |
| Older RBCs only | P. malariae |
| RBCs of all ages | P. falciparum and P. knowlesi โ very high parasitemia possible |
| Duffy antigen | P. vivax needs Duffy antigens to invade โ Duffy-negative people resist P. vivax (almost absent in West Africa) |
| Hb and enzyme polymorphisms | Hb S, Hb C, Hb E, ฮฑ- and ฮฒ-thalassemia, G6PD deficiency protect against severe falciparum malaria (infection still occurs). Proposed: enhanced phagocytosis of ring-infected cells (sickle trait, ฮฒ-thal trait, G6PD), โ PfEMP1 display (Hb S trait, Hb C), โ invasion (Hb E trait) |
2.17 Malaria โ Clinical & Laboratory Findings
| Feature | Details |
|---|---|
| Symptoms | Fever, chills, rigors, sweating, headache, muscle pain, nausea, diarrhea. Severe: jaundice, splenomegaly, hepatomegaly, shock, bleeding, seizures, coma. Chronic/repeated infection โ massively enlarged spleen |
| WBC | Normal to slightly โ during fever; neutropenia may develop during chills and rigors |
| Reticulocytes | Decreased in chronic malaria with anemia (inflammation suppresses erythropoiesis) |
| Severe malaria labs | Metabolic acidosis ยท glucose <40 mg/dL ยท โ lactate ยท โ creatinine ยท Hb <5 g/dL ยท hemoglobinuria ยท hyperparasitemia |
2.18 Malaria โ Microscopic Examination (Thick & Thin Films)
| Feature | Details |
|---|---|
| Timing | Collect before treatment; prepare films as soon as possible after venipuncture |
| Specimen | At least two thick and two thin films from EDTA blood (or capillary puncture) |
| Stain | Wright-Giemsa (Giemsa) |
| Thick film | Concentrates parasites โ ideal for initial screening (detection). Stained with water-based stain without methanol fixation โ RBCs lyse |
| Thick film prep (Box 25-3) | 3 small drops close together; stir ~30 s with slide corner over an area 1โ2 cm in diameter; air-dry thoroughly; water-based Giemsa |
| Thin film | Species identification and % parasitemia; methanol-fixed (RBCs preserved) |
| % Parasitemia | Count parasitized RBCs (asexual stages) among 500โ2000 RBCs on the thin film โ percentage |
| Before reporting negative | Examine โฅ300 fields on thick and thin films with the 100ร objective |
| Repeat sampling | Every 8โ12 hours โ parasite numbers vary with schizogony timing; one negative set doesn’t rule out malaria |
| Sensitivity | Microscopy detects 5โ20 parasites/ยตL (~0.0001% parasitemia) |
| Pitfall | A platelet on top of an RBC can be mistaken for a parasite |
2.19 Plasmodium Species on the Thin Film
| Feature | P. falciparum | P. vivax | P. ovale | P. malariae | P. knowlesi |
|---|---|---|---|---|---|
| Geography | Sub-Saharan Africa, Saudi Arabia, Haiti, Dominican Republic; Asia, SE Asia, South America | Asia, South and Central America (~40% of cases worldwide); rare in Africa | West Africa, India | Worldwide, low frequency; East Africa, India | Malaysia; Myanmar, Philippines, Thailand |
| RBC age infected | All ages | Reticulocytes | Reticulocytes | Older RBCs | All ages |
| Infected RBC size | Normal | Enlarged | Enlarged, oval, fringed | Normal (not enlarged) | Normal* |
| Stippling | Maurer clefts* | Schรผffner (all stages except early rings) | Schรผffner (all stages, including early rings) | None | None* |
| Ring forms | Small, easily missed; multiple rings per cell; rings at cell periphery (appliquรฉ) | Delicate, red chromatin dot, blue cytoplasm | Larger, more ameboid than P. vivax | Smaller and wider than P. vivax | Like P. falciparum; multiple rings, high parasitemia |
| Trophozoite | Not usually in blood (sequestered) | Ameboid, fine light-brown pigment, nearly fills RBC | Round, compact | Band form across the cell, dark brown pigment | Band form like P. malariae |
| Mature schizont | Not usually in blood (sequestered) | 12โ24 merozoites | 8โ12 merozoites | 6โ12 merozoites, rosette around clumped pigment | Average 16 merozoites, no rosettes |
| Gametocyte | Crescent/banana-shaped, deep blue cytoplasm, central red chromatin, brownish pigment | Round, blue cytoplasm, light-brown pigment (micro-/macrogametocyte) | Like P. vivax but smaller | Like P. vivax but smaller | โ |
| Forms seen in blood | Only rings and gametocytes | All stages | All stages | All stages | All stages |
| Erythrocytic cycle | 36โ48 h | 44โ48 h | 48 h | 72 h | 24 h |
| Parasitemia / severity | Very high (>50% possible); severe malaria | Usually lower; relapse (hypnozoites) | Usually benign; relapse (hypnozoites) | Usually benign | High parasitemia, rapid severe disease |
*Maurer clefts and the knowlesi RBC size/stippling entries are from general parasitology references, not stated in Rodak Ch. 25.
2.20 Malaria โ Other Tests & Treatment
| Feature | Details |
|---|---|
| Fluorescent dyes | Sensitive for detection; not useful for speciation |
| Molecular (PCR) | Detection and speciation; helpful in mixed infections, low parasitemia and P. knowlesi |
| Rapid antigen test | BinaxNOW Malaria (FDA-approved): detects P. falciparum histidine-rich protein II (HRP-II) and generic Plasmodium aldolase. Low sensitivity at <100 parasites/ยตL โ always do thick and thin films too |
| Standard drugs | Chloroquine or hydroxychloroquine โ except chloroquine-resistant P. falciparum and P. vivax |
| Resistant strains | Combination therapy: atovaquone-proguanil, quinine sulfate + doxycycline or tetracycline, mefloquine; artemether-lumefantrine for resistant P. falciparum |
| Hypnozoites | Primaquine for P. vivax and P. ovale to prevent relapse โ test for G6PD deficiency first |
| Severe anemia | Transfusion; exchange transfusion if parasitemia >10% |
| Urgency | P. falciparum and P. knowlesi can be rapidly fatal โ treat without delay once diagnosed |
2.21 Babesiosis
| Feature | Details |
|---|---|
| Organism / vector | Intraerythrocytic protozoa, genus Babesia; tick-transmitted. B. microti is the most common U.S. cause (‘Nantucket fever‘, first cluster 1969). Sexual cycle in the tick Ixodes scapularis; asexual cycle in the white-footed mouse (reservoir) |
| Other transmission | Blood transfusion from asymptomatic donors (159 U.S. cases 1979โ2009); rarely congenital |
| Geography | B. microti: southern New England, New York, New Jersey, Wisconsin, Minnesota ยท B. duncani: northern California, Washington ยท B. divergens-like: Missouri, Kentucky, Washington ยท B. divergens and B. venatorum: Europe |
| Clinical | Incubation 1โ9 weeks; ~โ asymptomatic; mild to severe hemolytic anemia with fever and flu-like symptoms; jaundice, splenomegaly, hepatomegaly possible. Severe disease: ARDS, heart failure, renal failure, DIC โ more common >50 years and with asplenia, malignancy, immunosuppression, HIV. Mortality <10% |
| Labs | Hemolytic anemia (โ Hb, โ retics, โ haptoglobin, bilirubinemia); leukopenia, thrombocytopenia, hemoglobinuria, proteinuria, abnormal renal/liver tests |
| Film | Tiny rings (round, oval, ameboid) with dark purple chromatin and scant cytoplasm around a vacuole; multiple rings per RBC; tetrads (‘Maltese cross’) |
| vs P. falciparum | Babesia: pleomorphic rings, no hemozoin pigment, no gametocytes, tetrads; extracellular forms* |
| Parasitemia | <1% early; up to 80% in asplenic patients |
| Other tests | IgG/IgM indirect immunofluorescent antibody (sensitivity 88โ96%); PCR for species identification |
| Treatment | Azithromycin + atovaquone or clindamycin + quinine; exchange transfusion if >10% infected or organ failure; asymptomatic cases usually untreated |
*Extracellular Babesia forms are a common textbook differentiator, not stated in Rodak Ch. 25.
2.22 Clostridial Sepsis
| Feature | Details |
|---|---|
| Organism | Clostridium perfringens โ anaerobic gram-positive bacillus; very rapid growth (7-minute doubling time) |
| Mechanism | ฮฑ-toxin with phospholipase C and sphingomyelinase activity hydrolyzes membrane phospholipids โ RBCs become spherical and extremely osmotically fragile โ sudden massive intravascular hemolysis |
| Findings | Dark red plasma and urine; Hct may fall below 10%; can trigger DIC and renal failure |
| Film | Spherocytes, microspherocytes, toxic changes in neutrophils |
| Risk factors | Malignancies (GU, GI, hematologic), solid organ transplant, postpartum/post-abortion, biliary surgery, acute cholecystitis, deep wounds |
| Prognosis | Grave, often fatal despite transfusion, antibiotics, fluids |
2.23 Bartonellosis (Carriรณn Disease)
| Feature | Details |
|---|---|
| Organism / vector | Bartonella bacilliformis โ small, pleomorphic intracellular coccobacillus; bite of female sandfly; endemic in Peru, Ecuador, Colombia |
| Mechanism | Bacteria adhere to RBCs; protein deformin causes pits/invaginations in the membrane โ hemolysis |
| Stage 1 โ Oroya fever | Acute hemolytic anemia: fever, malaise, headache, chills โ pallor, jaundice, lymphadenopathy; rapid hemolysis, Hct <20% in two thirds |
| Stage 2 โ verruga | Chronic stage: skin lesions and warts on extremities, face, trunk |
| Film | Coccobacilli on RBCs (Wright-Giemsa) โ up to 80% of RBCs in the acute phase; polychromasia, nRBCs, mild leukocytosis with left shift |
| Diagnosis | Blood culture + film; serology (IFA, immunoblot) ~89% sensitive |
| Treatment / mortality | Transfusion, ciprofloxacin or chloramphenicol. Mortality ~10% hospitalized, ~90% untreated |
| History | Named for Daniel Alcides Carriรณn, a Peruvian medical student who inoculated himself in 1885, linking both stages to one agent |
2.24 Drugs, Chemicals, Venoms & Burns
| Feature | Details |
|---|---|
| Oxidant drugs/chemicals | Oxidative denaturation of Hb โ methemoglobin and Heinz bodies even in normal RBCs: dapsone (leprosy, dermatitis herpetiformis), naphthalene (mothballs). G6PD-deficient cells are especially sensitive (e.g., primaquine) |
| Other chemicals | High levels of arsine hydride, copper, lead |
| Drug hemolysis labs | โ Hb, โ retics, โ indirect bilirubin, โ haptoglobin; Heinz bodies with supravital stain only (round blue granules on inner membrane) |
| Venoms | Snakes (some cobras, pit vipers), brown recluse spider (Loxosceles reclusa, L. laeta), multiple bee/wasp stings (โฅ50). Acute or delayed โฅ1 day. Mechanisms: direct membrane disruption, complement-mediated lysis, DIC. Severe: renal failure, death |
| Extensive burns | Heating RBCs to 49 ยฐC in vitro causes fragmentation and budding. Burn patients: schistocytes, spherocytes, microspherocytes; damaged cells cleared by spleen within 24 hours |
| Other burn anemia causes | Blood loss (excision/grafting), nutritional deficiency, impaired metabolism, anemia of chronic inflammation |
| Blood warmers | Overheating in malfunctioning warmers โ fragmentation/hemolysis of donor RBCs |
3 ยท Visual Memory Hooks
โSchisto + Low Plts = Micro-Angioโ โ every MAHA fragments RBCs; platelets consumed in thrombi.
โDIC Disturbs the Clotting testsโ โ PT/PTT prolonged only in DIC; TTP, HUS, HELLP have normal PT/PTT.
โADAMTS-13 = VWF scissorsโ โ no scissors โ giant sticky VWF โ platelet clots.
โExchange the Plasma, Exchange the Fateโ โ 80โ90% respond; inherited just needs FFP.
โHamburger โ Bloody diarrhea โ Broken kidneysโ โ E. coli O157:H7, children, Gb3 (CD77).
โAtypical = Alternative complementโ โ eculizumab.
โHemolysis, Enzymes (AST), Low Platelets โ Pregnantโ; PT/PTT normal; deliver.
โValves slice (schistocytes); Feet squash (no schistocytes)โ โ platelets normal in both.
โLeaky valve โ leaky ironโ โ hemosiderinuria, โ ferritin, microcytosis.
โKnowlesi Kwik 24, Vivax & Ovale 48, Malariae 72โ; falciparum 36โ48.
โVivax & Ovale Very young (retics); Malariae Mature; Falciparum & Knowlesi Feast on allโ.
โBig Vivax, Oval Ovale โ both Schรผffnerโ.
โFalciparum = Few forms: rings and bananas onlyโ.
โMalariae = Band and Bouquet (rosette)โ.
โKnowlesi Knocks off falciparum rings and malariae bandsโ โ needs PCR.
โVivax and Ovale Visit againโ (relapse) โ primaquine after G6PD test.
โThick to Tell if present; Thin to Tell which oneโ.
โThick = No methanol, RBCs Lyseโ.
โNo Duffy, No Vivaxโ.
โBabesia = Maltese cross, No pigment, No gametocytes, Tick-borneโ.
โClostridium Chews Lipidsโ โ ฮฑ-toxin (phospholipase C) โ spherocytes, Hct <10%.
โ49 ยฐC Breaks cellsโ โ schistocytes + microspherocytes within 24 h.
Pattern Triggers
| If you seeโฆ | Thinkโฆ | Becauseโฆ |
|---|---|---|
| Schistocytes + platelets 18 ร 10โน/L + markedly โ LDH + normal PT/PTT + neuro signs | TTP | ADAMTS-13 deficiency; coagulation not consumed |
| Child, bloody diarrhea 1 week ago, schistocytes, โ creatinine, casts | Typical (stx) HUS | Shiga toxin damages glomerular endothelium |
| Schistocytes, thrombocytopenia, prolonged PT/PTT, โ fibrinogen, โ D-dimer | DIC | Consumption of factors |
| Third trimester, preeclampsia, โ AST, platelets 70, schistocytes, normal PT/PTT | HELLP syndrome | Placental endothelial dysfunction |
| Prosthetic valve, schistocytes, normal platelets, hemosiderinuria, โ ferritin | Traumatic cardiac hemolytic anemia | Turbulence/paravalvular leak |
| Marathon runner, hemoglobinuria after race, no schistocytes | Exercise-induced hemoglobinuria | Foot-strike trauma |
| Traveler from West Africa, multiple small rings, appliquรฉ forms, crescent gametocytes | P. falciparum | Only rings and gametocytes circulate |
| Enlarged RBCs with Schรผffner stippling, ameboid trophozoite | P. vivax | Invades retics |
| Oval, fringed, enlarged RBCs with Schรผffner dots | P. ovale | Distinctive oval shape |
| Band-form trophozoites, rosette schizonts, normal-size RBCs | P. malariae | 72-hour cycle |
| Malaysia traveler, falciparum-like rings + malariae-like bands, high parasitemia | P. knowlesi | 24-hour cycle โ urgent |
| Northeast U.S., tick exposure, tiny pleomorphic rings, tetrads, no pigment | Babesiosis (B. microti) | Ixodes tick-borne |
| Postabortion sepsis, Hct 8%, dark red plasma, many spherocytes | Clostridial sepsis | ฮฑ-toxin phospholipase C |
| Peru, fever, rapid hemolysis, coccobacilli on RBCs | Bartonellosis (Oroya fever) | Sandfly-borne B. bacilliformis |
| Extensive burns, microspherocytes and schistocytes on day 1 | Thermal injury hemolysis | Heat damage at 49 ยฐC |
| Dapsone therapy, Heinz bodies, normal G6PD | Oxidant drug hemolysis in normal RBCs | High-dose oxidant stress |
Commonly Confused Pairs
| Feature | A | B |
|---|---|---|
| TTP vs HUS | Severe โ platelets, neuro, ADAMTS-13 <5โ10% | Mildโmoderate โ platelets, renal failure, Shiga toxin/complement |
| TTP vs DIC | PT/PTT normal | PT/PTT prolonged, โ fibrinogen, โ D-dimer |
| HELLP vs DIC | PT/PTT normal, โ AST | PT/PTT prolonged |
| Idiopathic vs inherited TTP | Autoantibody (IgG) present; plasma exchange | No antibody; ADAMTS13 mutation; FFP infusion |
| Typical vs atypical HUS | 90%, Shiga toxin, children, supportive | 10%, complement, eculizumab |
| Cardiac vs exercise hemolysis | Schistocytes present | Schistocytes absent (rarely present) |
| Thick vs thin film | Detection; no methanol, RBCs lysed | Species ID and % parasitemia; methanol-fixed |
| P. vivax vs P. ovale | Enlarged, round; 12โ24 merozoites; no stippling in early rings | Enlarged, oval, fringed; 8โ12 merozoites; stippling in all stages |
| P. malariae vs P. knowlesi | Rosettes, 72 h, low parasitemia | No rosettes, 24 h, high parasitemia |
| P. falciparum vs Babesia | Hemozoin pigment, banana gametocytes | No pigment, no gametocytes, tetrads |
| Malaria vs babesiosis vector | Female Anopheles mosquito | Ixodes tick |
| Parasite vs platelet over an RBC | Ring with chromatin dot inside the RBC | Platelet sits on top, with a halo, granular |
Timeline Table
| Condition / Marker | Onset | Peak / Key Point | Duration | Best Exam Use |
|---|---|---|---|---|
| Stx-HUS renal damage | 5โ13 days after diarrhea | Oliguria | Resolves in 1โ3 weeks | Link to recent gastroenteritis |
| TTP indirect bilirubin | Delayed several days after onset | โ | โ | LDH rises first |
| Malaria liver stage | 5โ16 days after bite | Hepatocyte rupture โ merozoites | Hypnozoites monthsโyears (vivax, ovale) | Incubation/relapse |
| Erythrocytic cycle | โ | Knowlesi 24 h ยท falciparum 36โ48 ยท vivax 44โ48 ยท ovale 48 ยท malariae 72 | Repeating | Species ID |
| Repeat malaria films | Every 8โ12 hours | Parasitemia varies with schizogony | Until 3 sets* | One negative doesn’t exclude |
| Babesia incubation | 1โ9 weeks | Symptoms weeks to months | โ | History timing |
| Burn RBC damage | Immediate | Cleared by spleen within 24 h | โ | Rodak Q10 timing |
| Venom hemolysis | Acute or delayed โฅ1 day | โ | โ | Delayed presentation |
*’Three sets’ is CDC practice, not stated in Rodak Ch. 25.
4 ยท Diagnostic Flowcharts
Flowchart 1 โ Schistocytes on the film
| Schistocytes + hemolysis markers | โ | Check platelet count |
| Platelets normal | โ | Macroangiopathic โ prosthetic/diseased valve (or rarely exercise); check hemosiderinuria, ferritin |
| Platelets decreased | โ | MAHA โ check PT/PTT, fibrinogen, D-dimer |
| PT/PTT prolonged, โ fibrinogen, โ D-dimer | โ | DIC |
| PT/PTT normal | โ | TTP, HUS or HELLP โ next flowchart |
| โ ๏ธ Common mistake: calling every schistocyte case ‘DIC’. DIC shows schistocytes in only about half of cases, and TTP/HUS/HELLP have normal PT/PTT. | ||
Flowchart 2 โ MAHA with normal PT/PTT
| Pregnant, third trimester, โ AST | โ | HELLP syndrome โ delivery |
| Child, bloody diarrhea, acute renal failure | โ | Typical (stx) HUS โ supportive care |
| Renal failure, no diarrhea, complement abnormality | โ | Atypical HUS โ eculizumab |
| Adult, severe โ platelets (10โ30), markedly โ LDH, ยฑ neuro signs | โ | TTP โ ADAMTS-13 activity/inhibitor; start plasma exchange urgently |
| ADAMTS-13 <5โ10% + autoantibody | โ | Idiopathic TTP ยท no antibody โ inherited (Upshaw-Schรผlman) โ FFP |
| โ ๏ธ Common mistake: waiting for the ADAMTS-13 result before treating โ TTP needs plasma exchange quickly. | ||
Flowchart 3 โ Suspected malaria
| Fever + travel to endemic area | โ | Collect EDTA blood before treatment |
| Thick films (water-based Giemsa, no methanol) | โ | Screen for parasites |
| Thin films (methanol-fixed) | โ | Identify species + count % parasitemia (500โ2000 RBCs) |
| Negative after โฅ300 fields at 100ร | โ | Repeat every 8โ12 h; add rapid antigen test/PCR |
| Positive | โ | Report species and parasitemia urgently; falciparum/knowlesi = emergency |
| โ ๏ธ Common mistake: reporting a negative result from one set of films, or mistaking a platelet on an RBC for a ring form. | ||
Flowchart 4 โ Identifying the Plasmodium species on the thin film
| Only small rings (multiple, appliquรฉ) + crescent gametocytes; normal RBC size | โ | P. falciparum |
| Enlarged RBC, Schรผffner stippling, ameboid trophozoite, 12โ24 merozoites | โ | P. vivax |
| Enlarged, oval, fringed RBC, stippling in all stages, 8โ12 merozoites | โ | P. ovale |
| Normal RBC size, band forms, rosette schizont (6โ12) | โ | P. malariae |
| Falciparum-like rings + malariae-like bands, ~16 merozoites, no rosette, Malaysia | โ | P. knowlesi โ PCR |
| โ ๏ธ Common mistake: calling P. knowlesi ‘P. malariae’ โ the 24-hour cycle makes it dangerous. | ||
Flowchart 5 โ Intracellular ring forms: malaria or Babesia?
| Rings inside RBCs | โ | Look for pigment, gametocytes, tetrads, history |
| Hemozoin pigment or crescent/round gametocytes | โ | Malaria |
| No pigment, no gametocytes, pleomorphic rings, tetrads (Maltese cross) | โ | Babesia |
| History | โ | Mosquito/travel โ malaria ยท tick exposure, NE U.S., asplenia, transfusion โ Babesia |
| Confirm | โ | Babesia: IFA serology, PCR ยท Malaria: rapid antigen, PCR |
| โ ๏ธ Common mistake: diagnosing P. falciparum from multiple small rings alone โ Babesia also has multiple rings per cell. | ||
Flowchart 6 โ Spherocytes with sudden massive hemolysis
| Spherocytes/microspherocytes + dark red plasma and urine | โ | Check DAT and history |
| DAT positive | โ | Immune hemolysis (next chapter) |
| DAT negative + sepsis risk (postabortion, GI cancer, biliary surgery) | โ | Clostridial sepsis โ blood cultures, urgent antibiotics |
| DAT negative + extensive burns | โ | Thermal injury |
| DAT negative + snake/spider/multiple stings | โ | Venom |
| โ ๏ธ Common mistake: attributing all spherocytes to HS or autoimmune hemolysis โ acquired toxins and heat produce them too. | ||
5 ยท 25 High-Yield Facts
| # | Fact |
|---|---|
| 1 | In extrinsic hemolytic anemias the RBCs are structurally and functionally normal. |
| 2 | Intravascular RBC fragmentation is a feature of all microangiopathic hemolytic anemias. |
| 3 | Schistocytes plus thrombocytopenia characterize microangiopathic hemolytic anemia. |
| 4 | TTP is caused by severe deficiency of ADAMTS-13, the VWF-cleaving protease. |
| 5 | Idiopathic TTP is due to autoantibodies, usually IgG, that inhibit ADAMTS-13. |
| 6 | Inherited TTP (Upshaw-Schรผlman syndrome) is caused by ADAMTS13 gene mutations. |
| 7 | In TTP, platelets are typically 10โ30 ร 10โน/L and LDH is markedly increased. |
| 8 | PT and PTT are usually normal in TTP, HUS and HELLP but prolonged in DIC. |
| 9 | About 80โ90% of idiopathic TTP patients respond to plasma exchange. |
| 10 | Typical HUS (90%) follows Shiga toxinโproducing E. coli such as O157:H7 infection, mostly in children. |
| 11 | Shiga toxin binds the Gb3 (CD77) receptor on endothelial cells. |
| 12 | Atypical HUS is caused by uncontrolled activation of the alternative complement pathway. |
| 13 | HELLP syndrome shows hemolysis, elevated AST, platelets below 100 ร 10โน/L and normal PT/PTT. |
| 14 | DIC shows prolonged PT/PTT, decreased fibrinogen and increased D-dimer; schistocytes in about half. |
| 15 | Traumatic cardiac hemolysis shows schistocytes with a normal platelet count. |
| 16 | Chronic hemoglobinuria from valve hemolysis causes hemosiderinuria and low serum ferritin. |
| 17 | Exercise-induced hemoglobinuria usually shows no schistocytes and is a diagnosis of exclusion. |
| 18 | P. vivax and P. ovale form hypnozoites that cause relapse; primaquine requires prior G6PD testing. |
| 19 | P. vivax and P. ovale invade reticulocytes; P. malariae older cells; P. falciparum and P. knowlesi all ages. |
| 20 | Duffy-negative individuals are resistant to P. vivax. |
| 21 | Only ring forms and crescent-shaped gametocytes of P. falciparum are usually seen in peripheral blood. |
| 22 | P. knowlesi has a 24-hour erythrocytic cycle; P. malariae has a 72-hour cycle. |
| 23 | Thick films are for detection (no methanol fixation); thin films are for species ID and parasitemia. |
| 24 | Babesia shows tetrads (Maltese cross) and lacks hemozoin pigment and gametocytes. |
| 25 | Clostridium perfringens ฮฑ-toxin (phospholipase C) causes massive intravascular hemolysis with spherocytes. |
Schistocytes + โ platelets: check PT/PTT. Prolonged โ DIC. Normal โ TTP (adult, severe โ platelets, โโ LDH, neuro), HUS (child, diarrhea, kidneys) or HELLP (pregnancy, โ AST). Schistocytes + normal platelets โ prosthetic valve. For malaria, remember the RBC size, stippling, forms present and cycle length for each species.
Quick Interpretation Table
| Lab Finding | Clinical Interpretation |
|---|---|
| 24-year-old back from Ghana; fever; Hb 8.7; multiple small rings, appliquรฉ forms; banana gametocyte on thick film | P. falciparum malaria (Rodak case study) |
| Seizure, Hb 7.8, platelets 18, schistocytes, helmet cells, โโ LDH, normal PT/PTT | TTP (Rodak Q11) |
| Rhode Island vacation, ameboid rings and tetrads, platelets 134 | Babesiosis (Rodak Q9) |
| ADAMTS-13 activity 3%, inhibitor present | Idiopathic (autoimmune) TTP |
| Platelets 60, creatinine โ, RBC casts, bloody diarrhea 7 days ago, child | Typical (stx) HUS |
| Platelets 45, AST 900 U/L, normal PT/PTT, 34 weeks pregnant | HELLP syndrome (severe โ platelets <50) |
| Mechanical valve, normal platelets, schistocytes, ferritin 8 ng/mL, microcytosis | Traumatic cardiac hemolysis with iron deficiency |
| Parasitemia 12% P. falciparum, Hb 4.5 g/dL | Severe malaria โ consider exchange transfusion |
๐ด Flashcards โ Active Recall Practice
๐ Practice Quiz โ Test Your Knowledge
๐ชค Trap Questions โ Beat the Examiner
8 ยท Rapid Revision Sheet
MAHA Basics
- Normal RBCs, outside injury
- Shearing by microthrombi โ schistocytes
- Platelets consumed โ โ
- TTP ยท HUS ยท HELLP ยท DIC
- PT/PTT prolonged only in DIC
TTP
- ADAMTS-13 โ โ ULVWF โ plateletโVWF thrombi
- Adults, 4th decade, F > M
- Hb 8โ10 ยท plts 10โ30 ยท LDH โโ
- ADAMTS-13 <5โ10% (idiopathic/inherited)
- Plasma exchange 80โ90% ยท โ relapse ยท rituximab
TTP Types
- Idiopathic: IgG autoantibody
- Secondary: pregnancy, HSCT, HIV, cancer, quinine, ticlopidine, trimethoprim
- Inherited: Upshaw-Schรผlman, ADAMTS13 โ FFP
HUS
- Typical 90%: STEC O157:H7, Shigella, kids
- Bloody diarrhea โ 5โ13 d renal failure
- Stx-1/Stx-2 โ Gb3 (CD77)
- Atypical 10%: alternative complement โ eculizumab
- Plts mildโmod โ ยท creatinine โ ยท casts
HELLP & DIC
- HELLP: <1% pregnancies, 10โ20% severe preeclampsia
- Plts <100 (<50 worse) ยท AST โโ ยท PT/PTT normal
- Deliver ยท mortality mother 3โ5%, fetus 9โ24%
- DIC: PT/PTT โ, fibrinogen โ, D-dimer โ
- Schistocytes in ~ยฝ of DIC
Macroangiopathic
- Valves: schistocytes, normal plts
- Paravalvular leak โ severe
- Hemosiderinuria, โ ferritin โ microcytic
- Exercise: no schistocytes, โ Hp, hemoglobinuria
- Diagnosis of exclusion
Malaria Biology
- Female Anopheles โ sporozoites โ liver (5โ16 d)
- Ring โ trophozoite โ schizont โ merozoites
- Hypnozoites: vivax, ovale โ primaquine (G6PD!)
- Retics: vivax/ovale ยท old: malariae ยท all: falci/knowlesi
- Duffy-neg resist vivax
Species ID
- Falci: rings + bananas only, multiple rings, 36โ48 h
- Vivax: big RBC, Schรผffner, ameboid, 12โ24 mz, 44โ48 h
- Ovale: oval fringed, stippling all stages, 8โ12, 48 h
- Malariae: bands, rosette 6โ12, 72 h
- Knowlesi: falci rings + bands, 16 mz, 24 h
Malaria Lab
- EDTA before treatment ยท 2 thick + 2 thin
- Thick: water Giemsa, no methanol โ detect
- Thin: methanol โ species + % (500โ2000 RBCs)
- โฅ300 fields at 100ร ยท repeat q8โ12 h
- BinaxNOW: HRP-II + aldolase; <100/ยตL weak
Other Infections & Injury
- Babesia: Ixodes, tetrads, no pigment/gametocytes
- Babesia up to 80% asplenic ยท IFA ยท PCR
- C. perfringens: ฮฑ-toxin, spherocytes, Hct <10%
- Bartonella: sandfly, Peru, Oroya fever
- Burns: 49 ยฐC, schistocytes + microspherocytes <24 h
9 ยท Final Memory Map
- โ๏ธ EXTRINSIC NONIMMUNE HEMOLYSIS
- Microangiopathic (MAHA)
- TTP โ ADAMTS-13, plasma exchange
- HUS โ Shiga toxin (90%) / complement (10%)
- HELLP โ pregnancy, โ AST, delivery
- DIC โ PT/PTT โ, fibrinogen โ, D-dimer โ
- Macroangiopathic
- Traumatic cardiac โ schistocytes, normal platelets, iron loss
- Exercise-induced โ no schistocytes, exclusion diagnosis
- Malaria
- Life cycle, hypnozoites (vivax, ovale)
- Anemia: lysis, splenic removal, marrow suppression
- 5 species โ size, stippling, forms, cycle
- Thick vs thin films, rapid antigen, PCR
- Chloroquine / combinations / primaquine / exchange
- Babesiosis
- Ixodes tick, B. microti, transfusion
- Tetrads, no pigment or gametocytes
- Asplenia โ severe
- Bacterial
- Clostridial sepsis โ ฮฑ-toxin, spherocytes
- Bartonellosis โ Oroya fever, deformin
- Other RBC Injury
- Oxidant drugs/chemicals โ Heinz bodies
- Venoms โ snakes, brown recluse, stings
- Burns โ 49 ยฐC, microspherocytes
- Microangiopathic (MAHA)